Back to Rankings

AHCO

AdaptHealthD
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
View Chart
Current thesis
The best-supported bullish interpretation is that Q1 proved demand and onboarding strength even in a messy transition: revenue rose to $819.8 million, organic growth was 9.1%, and full-year revenue guidance was raised to $3.45-$3.52 billion while EBITDA and free-cash-flow guidance were maintained. The April refinancing and planned August note redemption also support a cleaner balance-sheet narrative.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
Elevated onboarding labor costs from the new strategic partner may take longer than expected to normalize, delaying margin recovery.
Momentum
17
Value
69
Sentiment
59
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $12.50 · Bull $15.50 · Bear $8.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $12.88
Why
Momentum17 · Δ7d -15.2
Value69 · Δ7d +0.1
Sentiment59 · Δ7d +10.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
17
34% active weight
Current posture
7d trendSoftening
Δ7d
-15.2
Δ21d
-60.8
Value
69
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.4
Sentiment
59
33% active weight
Current posture
7d trendImproving
Δ7d
+10.0
Δ21d
+21.2
Why this grade

Composite grade D. Momentum 16.8 / Value 68.6 / Sentiment 59.2

Fundamentals (TTM)
As of 2026-06-02
Market Cap
$1.31B
Beta
1.73
Shares Out
135.42M
P/E (TTM)
17.6
P/S (TTM)
0.41
P/FCF (TTM)
6.21
Rev YoY
+1.8%
EPS YoY
+6.8%
Gross Margin
+25.3%
Op Margin
+8.0%
Net Debt
$1.91B
Current Ratio
1.08
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology